Recent Articles from Investor Brand Network

FingerMotion (NASDAQ: FNGR) entered into a binding memorandum of understanding to acquire land rights and permitting for a 9.9 megawatt behind-the-meter power generation and compute site in the County of Newell, Alberta, approximately 185 kilometers southeast of Calgary. The site represents the first acquisition in the company’s planned Brooks Campus Zone, where FingerMotion intends to assemble separately owned and permitted 9.9 MW sites as demand for powered land develops. Adjacent to an operating third-party natural gas facility, the site is designed to generate and consume power behind the meter without requiring a grid interconnection request, transmission service arrangement or position in an interconnection queue. FingerMotion is targeting a fully permitted site within 120 days of release to work and plans to advance energization only against contracted demand backed by a take-or-pay agreement and funded customer deposit.

VERAXA Biotech (NASDAQ: VRXA) recently appointed antibody therapeutics specialist Dr. Christoph Erkel as its chief scientific officer, taking responsibility for advancing the company’s proprietary BiTAC(R) technology and broader oncology pipeline toward clinical development. The company’s lead BiTAC-TCE program uses a conditionally active, dual-targeting approach designed to selectively activate T cells against cancer cells while potentially limiting effects on healthy tissue. Recent scientific advice from Germany’s Paul-Ehrlich-Institute provided additional clarity around the program’s proposed non-clinical development strategy, while preclinical data presented at the AACR Annual Meeting showed selective activity against cells expressing both target molecules. Beyond BiTAC, VERAXA is developing bispecific antibody-drug conjugates and other engineered antibody therapies, positioning the company to pursue multiple approaches to next-generation cancer treatment.

AmpliTech Group (NASDAQ: AMPG, AMPGZ) received approximately $7.3 million in follow-on orders supporting deployments for an Asian mobile network operator (“MNO”) under its previously announced 5G O-RAN radio Letter of Intent (“LOI”) program. The orders follow deployment of AmpliTech O-RAN radios at end-customer 5G sites and represent renewed purchasing activity under the program. The company said the orders, together with recently received follow-on orders supporting its North American MNO program, restore momentum under the LOI program and support its efforts to convert its opportunity pipeline into shipments and revenue.

The latest insights from the World Gold Council suggest that gold prices may face additional downside as the current momentum diminishes. This outlook comes amid conflicting signals from the U.S. Treasury Department and the Federal Reserve, which have created a complex environment for the precious metal.

Investor conferences can take a lot of different forms. Some lean heavily toward networking, while others focus primarily on company presentations and scheduled investor meetings.

Earth Science Tech (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, combining compounding pharmacy, telemedicine, clinical support, and fulfillment capabilities. Its B2B and B2C business model allows the company to serve independent clinics while also selling customized medications directly to consumers, creating diversified revenue streams across physical and digital healthcare operations. In FY2026, ETST reported revenue of $35.7 million, up from $33.1 million in FY2025 and $11.95 million in FY2024, while also reporting positive operating cash flow and a stronger balance sheet. The company reduced total liabilities from $3.146 million to $1.928 million, increased assets from $7.066 million to $8.969 million, and fully repaid its long-term debt. ETST says it expects operating cash flow to fund its FY2027 needs without additional dilutive financing, highlighting its strategy of pursuing growth through internally generated cash rather than debt or shareholder dilution.

Silver Bow Mining (NYSE American: SBMT) announced that the U.S. Bankruptcy Court for the District of Montana approved the sale of specified Montana Tunnels Mining assets comprising the Jefferson County Metallurgical Complex to Silver Bow and its wholly owned subsidiary, Silver Bow Tunnels Corp. The company also completed the initial closing under its previously announced definitive asset purchase agreement after funding approximately $28.58 million into escrow to satisfy specified creditor obligations, including approximately $4.27 million owed to Jefferson County and $20.78 million in specified obligations to the Montana Department of Environmental Quality.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system.

SKYX Platforms (NASDAQ: SKYX) signed a merger agreement with Silicon Valley-backed smart home AI platform and intelligent lighting company Deako Inc., combining the companies plug-and-play technologies across ceiling outlets, wall outlets and wall switches. Deako has shipped more than 32 million units over the past five years, generated more than $26 million in revenue in 2025 and supplies more than 50 U.S. builders. SKYX said the combination is expected to accelerate deployment of its technologies through Deako builder footprint while creating opportunities for Deako products across SKYX hotel and development projects.

Perpetuals.com (NASDAQ: PDC) and the European Institute of Management (“EIM”) launched a joint research group pairing more than 20 doctoral researchers with Perpetuals to develop AI-powered trading models combining machine learning and crowd intelligence. The researchers will have access to Perpetuals proprietary trading datasets and live venue data, with work focused on behavioral finance, trader performance classification, market microstructure and model risk. The initiative is expected to run for at least three years, with more than half of the participating researchers currently employed by Perpetuals.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

Public safety technology is increasingly moving beyond individual products as organizations seek solutions that combine technology with training, situational awareness, real-world scenarios, and continuous professional development. Wrap Technologies (NASDAQ: WRAP) is positioning itself at the intersection of these capabilities as it works to expand its public safety platform across a broader range of applications.

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

As the week got started, copper prices on the London Metal Exchange (LME) climbed to their highest-ever level as markets increasingly expected that President Trump would expand tariffs on imports to include refined copper.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

The Group of Seven (G7) is encouraging organizations to commence preparations for a future in which quantum computers could break the encryption used to protect digital systems. The warning, issued by the G7 working group on cybersecurity on Sept. 3, has important implications for the cryptocurrency industry, even though the report does not mention crypto directly.

Coal prices rose across major international markets last week as coal supply disruptions met firm demand. The gains were particularly visible in Asia, where 5,500 NAR coal at Qinhuangdao moved above $120 a short ton. Lower inventories and tighter spot availability helped support the increase, while chemical and cement makers stepped up restocking ahead of a seasonal rise in production.

BioMedWire Editorial Coverage: Today’s multiple sclerosis treatments can slow down disease progression, but none of them halt it outright, and none give back the function patients have already lost. Close to a million people in the United States, and nearly 2.9 million worldwide, live with that reality, watching a condition that steadily chips away at mobility, eyesight and basic physical control. That gap in treatment options just picked up a serious new contender. Quantum BioPharma Ltd. (NASDAQ: QNTM) ( Profile ) has received U.S. Food and Drug Administration (“FDA”) clearance to launch a phase 2 trial of Lucid-MS, a patented, first-in-class candidate designed not to calm the immune system but to shield, and potentially rebuild, the myelin sheath itself. The clearance sets up what would be the first time in history that a drug built on this exact mechanism gets tested in people living with MS, a milestone significant enough that it has already drawn a fresh buy rating from Wall Street analysts. That momentum puts Quantum BioPharma squarely among a group of leading pharma companies, including Novartis AG (NYSE: NVS), Merck & Co. Inc. (NYSE: MRK), TG Therapeutics Inc. (NASDAQ: TGTX) and Bristol-Myers Squibb Company (NYSE: BMY), that are focused on treating serious diseases and areas of major…

SS Innovations International (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Sept. 8, 2026, up 79% from 7,885 at year-end 2025, while its installed base increased 42% to 238 systems from 168. The SSi Mantra is now installed across 12 countries, approximately 1,500 physicians have been trained on the platform and the system has been used for more than 170 types of surgical procedures. Recent international milestones include the launch of robotic cardiac surgery in Colombia, installation of the first SSi Mantra in Sri Lanka and the first telesurgery within the Philippines.

American Fusion (OTC: AMFN) announced the release of a new AGORACOM interview featuring Executive Chairman Brent Nelson discussing development of the company proprietary Texatron(TM) Fusion Engine(TM) and its strategy for addressing growing electricity demand from artificial intelligence, data centers and other power-intensive applications. Nelson discusses the company 5 MW preproduction Texatron(TM), plans for 10 MW and 20 MW systems and Texas authorization to test 12 planned system sizes ranging from approximately 500 kW to 1 GW, while noting the ratings are intended system sizes and not demonstrated electrical output.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics , is positioning itself among the several trends reshaping the global economy: persistent labor shortages, rising operating costs and accelerating adoption of AI-enhanced automation.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

This article has been disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Rezolve Ai (NASDAQ: RZLV) announced that Founder and CEO Daniel M. Wagner will participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York City, scheduled for Sept. 14-16, 2026. The company will also host an Investor Day on Oct. 6 at Nasdaq MarketSite in New York City, where it will present its agentic commerce business and expanding AI infrastructure capabilities to investors and analysts, with attendance available in person and online.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

American Fusion(TM) (OTCBQ: AMFN), a developer of next-generation fusion energy technologies, is entering a more consequential phase of its fusion program as recent testing updates coincide with new equity research coverage examining the company’s progress toward commercial validation.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Forward Industries (NASDAQ: FWDI) issued an open letter to SkyAI shareholders outlining concerns about the company and urging shareholders to vote against SkyAI’s 2026 Equity Incentive Plan and withhold votes on each of its five director nominees at the Sept. 18, 2026, annual meeting. Forward cited SkyAI’s rejection of its June 15 all-stock acquisition proposal valued at $1.55 per share, which represented a 20% premium to SkyAI’s prior closing price, as well as concerns regarding related-party arrangements, financial performance and shareholder value. Forward said SkyAI’s proxy disclosed $3.3 million in 2025 consulting fees to Sol Edge Limited and warrants valued at approximately $101.3 million issued to Sol Markets, entities it said are owned and controlled by the brother of SkyAI Chief Investment Officer and director Yuwen (Alice) Zhang.

Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, began the current fiscal year 2027 in a position of real financial strength, according to CEO and Board Chairman Giorgio R. Saumat letter to shareholders ( https://ibn.fm/NC6CW ). This position is the result of meaningful progress over the last several years, which built a business that is not only durable, self-sustaining, and positioned for long-term growth but also anchored in a conglomerate model, infrastructure as a service, and end-to-end vertical integration.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Junior mining stocks live and die by a single number: The price of whatever metal sits beneath their flagship projects. When that price falls, so does the company, regardless of how good the geology is. It is a structural weakness baked into most explorers’ business models, and it explains why single-asset miners trade at a discount and swing wildly with commodity headlines. Greenland Mines (NASDAQ: GRML) is ensuring it doesn’t operate in that space, having transformed from a company built around one palladium-gold-platinum deposit into one that now also controls a major rare earths project, a shift that creates a different view for interested investors.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, announced that CEO and Chairman John Yu, MD, will present a corporate overview in person at the H.C. Wainwright 28th Annual Global Investment Conference, taking place Sept. 14-16, 2026, at the Lotte New York Palace Hotel.

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.

Recent weeks have seen the news dominated by reports of AI agents going rogue and hacking into sites and systems outside the controlled testing environments created by AI labs like OpenAI and Anthropic. The story of these rogue agents has taken on as many colors as the people narrating it, and we explore some of those narratives.

For many women, UTIs are something they routinely experience. These usually start as a burning sensation or a sudden urge to use the bathroom. For some, there is a sudden onset of discomfort that they just cannot ignore. While many receive a dose of antibiotics after being told what’s bothering them “is just a UTI,” several questions remain in the mind of the woman .

Europe’s wind sector looks set for its best year yet, with 8.8 GW of fresh turbine capacity installed across H1 of 2026 alone, up roughly 30% from the same stretch a year earlier. That pace has WindEurope forecasting 24 gigawatts of new capacity for the full year. This could push the industry meaningfully closer to its stated ambition of adding close to 30 gigawatts annually once the 2030s arrive.

Electric vehicles are having a brutal stretch in the United States . Their share of the new-car market hit a record near 12% last September, right before a $7,500 federal EV incentive went away. By January that share had fallen to 6%, and Cox Automotive figures show sales dropped by a further 20% that month compared with December.

Bitcoin came under renewed pressure as last week ended, falling about 1.4% to roughly $77,000 after reaching around $77,500 earlier in the week. The decline erased a fraction of the crypto’s strong August performance, when it gained almost 25%.

Australia is considering a major change to the way social media platforms use recommendation algorithms. The government is weighing whether users should have to actively choose to use these systems instead of having them switched on automatically when they create an account.

The U.S. and the European Union are taking increasingly different approaches to AI, with Washington pressing for lighter regulation while Brussels moves ahead with enforcement of its new rules.

Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on Sept. 16, 2026, at Nasdaq MarketSite in New York. The summit will bring together biotechnology executives, investors and industry leaders for an evening of thought leadership and networking.

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, announced that company representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum, taking place Sept. 16-17, 2026, in Jersey City, New Jersey. CEO Eric Weisblum said the forum provides an opportunity to engage with experts in nasal drug development as Silo continues advancing SPC-15’s novel nose-to-brain approach to targeted drug delivery for the treatment of PTSD. Preclinical data showed that the SPC-15 formulation and device met predefined specifications for assay, impurities, pH and microbiological quality through nine months, while six-month accelerated stability data was consistent and aligned with long-term data.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Frontieras North America the energy and environmental technology company commercializing FASForm(TM) Solid Carbon Fractionation, announced it has entered into a Letter of Intent (“LOI”) with Cora Terminal, LLC, a joint venture between Watco Companies, LLC and SCH Services, LLC, for phased development of FASForm(TM) production capacity at the Cora Terminal in Rockwood, Illinois. Under the contemplated structure, Frontieras would initially lease approximately 85 acres for a plant designed to process 7,500 tons of coal feedstock per day, with a later expansion to approximately 130 acres for a second plant. At full two-plant buildout, the site would receive approximately 5.5 million net tons of coal feedstock annually and ship products including FASCarbon(TM), ultra-low-sulfur diesel, jet fuel, ammonium sulfate fertilizer, sulfuric acid and naphtha.

Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company focused on data monetization, credentialing, digital engagement, real-world asset (“RWA”) tokenization and spatial audio technologies, issued a statement in response to recently filed shareholder litigation and related notices being circulated by plaintiffs’ law firms. The company said it intends to vigorously defend itself against the claims, a number of which concern subjects previously raised in an Oct. 31, 2025, short-seller report by Wolfpack Research. Datavault AI and CEO Nathaniel Bradley subsequently filed litigation against Wolfpack Research and its founder, Dan David, alleging defamation, false light, tortious interference and unjust enrichment arising from that report. Datavault AI said it stands behind its public disclosures and does not intend to comment further on pending litigation except as appropriate or required by law.

Rail Vision (NASDAQ: RVSN, FSE: C80), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems, announced new branding for its existing MainLine and ShuntingYard products, which will now be marketed as TrackScout and YardFlow Flex, respectively. TrackScout is the company’s long-range AI perception system for mainline freight and passenger rail networks, detecting and classifying hazards in real time at ranges of up to 2,000 meters, while YardFlow Flex is designed for freight and industrial yards and detects on-track and near-track hazards at distances of up to 200 meters. Both systems incorporate capabilities including switch-state and anomaly detection and are complemented by Rail Vision’s operational intelligence platform, which uses big data analytics, real-time tracking and continuous event recording to provide fleetwide safety and efficiency insights.

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.

BOXABL (NASDAQ: BXBL) an innovative technology company transforming the housing market with its modular building systems, highlighted a portfolio of completed and in-progress projects demonstrating deployments of its factory-built housing system nationwide. Projects include a permanent 12-unit park-model RV Casita installation at American Campground in Las Vegas, wildfire relief support in Pasadena, California, a 12-unit stacked Casita project for Catholic Charities in Oklahoma City and the 12-unit Pasadera short-term rental community near Oklahoma State University.

Eco Wave (NASDAQ: WAVE) is a pioneering onshore wave energy company developing technology to convert ocean and sea waves into clean, reliable and cost-efficient electricity. As global electricity demand accelerates—driven in part by the rapid expansion of artificial intelligence, data centers and digital infrastructure—the company believes wave energy can emerge as an important new source of renewable power for the next generation of energy-intensive infrastructure.

Datavault AI(TM) (NASDAQ: DVLT) is an artificial intelligence and data monetization company focused on transforming data and real-world assets into secure, measurable and monetizable digital assets. The company has built an integrated technology ecosystem that combines artificial intelligence, data valuation, tokenization, cybersecurity, high-performance computing and exchange infrastructure to support the full lifecycle of data — from creation and authentication through valuation, licensing, tokenization and monetization.

Mobix Labs (NASDAQ: MOBX), a U.S.-based provider of advanced electronic components and connectivity solutions for aerospace, defense and mission-critical applications, announced its initial production order for components supporting the F-16 Fighting Falcon. The order, placed by a veteran-owned U.S. aerospace sustainment contractor supporting the U.S. Air Force F-16 fleet, includes EMI-filtered connectors manufactured at Mobix Labs military-approved facility in Irvine, California. Initial shipments have already been delivered, with the balance scheduled for delivery in the coming weeks.

Mobix Labs (NASDAQ: MOBX), a U.S.-based provider of advanced electronic components and connectivity solutions for aerospace, defense and mission-critical applications, announced its initial production order for components supporting the F-16 Fighting Falcon. The order, placed by a veteran-owned U.S. aerospace sustainment contractor supporting the U.S. Air Force F-16 fleet, includes EMI-filtered connectors manufactured at Mobix Labs military-approved facility in Irvine, California. Initial shipments have already been delivered, with the balance scheduled for delivery in the coming weeks.

Knightscope (NASDAQ: KSCP), a security technology company building an Autonomous Security Force, announced that Founder, Chairman and CEO William Santana Li will present at a Tribe Public webinar and Q&A event titled “Building America’s Autonomous Security Force With AI, Robotics, and Humans” on Sept. 10 at 11:30 a.m. ET. The presentation will examine Knightscope model combining autonomous machines, AI-driven software and human security professionals into an integrated operation. Knightscope said it currently serves 434 clients across 42 states and its machines have logged more than 4.4 million autonomous hours in the field. The company Autonomous Security Force is scheduled to officially launch at GSX 2026, being held Sept. 14-16 in Atlanta.

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company combining immunology therapeutic development with a revenue-generating contract development and manufacturing organization (“CDMO”), announced a strategic refocusing of its R&D portfolio following the Aug. 31 expiration and termination of its option and license arrangements with PinCell S.r.l. relating to PC111. Scinai said the decision was not driven by any new negative scientific finding regarding PC111 and will allow the company to concentrate R&D resources on its NanoAb platform while preserving capital and management capacity for its CDMO business. Scinai is advancing two IL-17 programs within the NanoAb platform, including an intradermal psoriasis program for which approximately €12 million in grant financing is under evaluation in Poland. The company also reported approximately $3.1 million in committed CDMO customer orders as of Aug. 16 and continues to pursue approximately $5 million in CDMO revenue for 2026, subject to project execution, timing, revenue recognition and additional business opportunities.

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising.

Roth Capital Partners is scheduled to host and sponsor more than a dozen investor events from September 2026 through June 2027, including seven ROTH-hosted conferences focused on healthcare, nuclear technology, solar and storage, technology and other growth sectors. Upcoming hosted events include the 5th Annual ROTH Healthcare Opportunities Conference on Sept. 29 in New York, the inaugural ROTH Critical Mass in Emerging Nuclear Technology on Oct. 1 in New York, the 13th Annual ROTH Solar & Storage Symposium at RE+ from Nov. 16-18 in Las Vegas and the 15th Annual ROTH Technology Conference from Nov. 17-18 in New York.

Wearable Devices (NASDAQ: WLDS), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, announced that it will showcase its neural sensing layer for Physical AI and humanoid robotics at Physical AI 2026 in Tel Aviv. The company technology is designed to complement vision-based training data with synchronized signals associated with human movement, muscle activation and intent. Wearable Devices said its multi-channel sEMG array captures motor unit action potentials before movement becomes visible and combines those signals with IMU and PPG data to generate hand-pose tracking, applied force, moment-of-touch and intent labels for Physical AI applications. The company is participating as a sponsor of the Sept. 8 event, which is being held in collaboration with Israel National AI Directorate.

Faraday Future (NASDAQ: FFAI) is a U.S.-based Physical AI ecosystem company dedicated to reshaping the future of robotics and mobility solutions through AI innovation and technologies. FF focuses on two major product strategies within the Embodied AI (“EAI”) robotics business: EAI humanoid and bionic robots, and EAI automotive-focused robots. By building a “Four-Core Full-Stack AI” ecosystem of EAI Brain, Device, Industry Productivity Solutions and Developer Platform, and Data Factory, FFAI aims to create an evolutionary flywheel: scaled device delivery, data collection and training, continuous evolution of the EAI Brain, stronger product capability, and even larger-scale delivery and deployment. Through this flywheel, FF seeks to maximize its commercial value and lead to the advancement of Physical AI. For more information, visit the company’s website at: https://www.ff.com/

Recent world geopolitical events have made one argument impossible to dismiss: Energy systems built around imported feedstocks and foreign supply chains carry risks that domestic production does not. Frontieras North America is working to strengthen its position in that domestic alternative, creating a production system that converts American coal into six essential byproducts, all within U.S. infrastructure and using a feedstock that never crosses a border or passes through a maritime chokepoint.

Cyabra (NASDAQ: CYAB) is an AI-powered narrative intelligence company that helps national security and defense organizations, government agencies, brands, communications agencies, and global enterprises restore trust and authenticity online by analyzing manipulated content, coordinated behaviors, and inauthentic actors. The platform helps teams understand who is operating, how activity is amplified, and where coordinated activity is shaping perception, translating evidence into clear mitigation steps. By reducing ambiguity and misdirected response, Cyabra enables proportionate, evidence-led action when clarity matters most. For more information, visit the company’s website at: https://www.cyabra.com

Researchers from the Washington University School of Medicine in St. Louis have found a way to improve brain cancer treatment: laser therapy . This technology has played an increasingly larger role in brain cancer therapy over the past 15 years as an alternative to open skull surgery. The research team has spent years studying a technique called laser interstitial thermal therapy, or LITT, to improve the overall treatment experience and outcomes for brain cancer patients.

Elon Musk and Mark Zuckerberg have called on G20 countries to support the rapid expansion of data centers needed to power the next stage of artificial intelligence. The technology leaders made their comments during a G20 meeting of technology ministers in Chapel Hill, North Carolina, as countries debate how to manage the fast growth of AI.

Impala Platinum, a South African giant in the global PGM industry, has paid out enhanced dividends to its shareholders after enjoying a year of bulked-up metal prices as PGMs saw their prices soar in a reversal of multiple years of dismal prices.

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.9 million worldwide, live with that reality, watching a disease that can gradually erode mobility, vision, and basic bodily control. That gap has just gotten a serious new challenger. Quantum BioPharma Ltd. (NASDAQ: QNTM) ( Profile ) has received FDA clearance to begin a phase 2 trial of Lucid-MS, a patented, first-in-class drug candidate aimed not at calming the immune system but at protecting and potentially repairing the myelin sheath itself. The clearance sets the stage for what would be the first time in history that a drug candidate built on this specific mechanism is tested in people living with the MS disease, a milestone significant enough that it has already drawn a fresh buy rating from Wall Street analysts. This momentum places Quantum BioPharma solidly in a group of leading companies focused on the treatment of serious diseases and areas of significant unmet medical need across vaccines, ophthalmology and neurological disease, including Sanofi (NASDAQ: SNY), Roche Holding AG (OTCQX: RHHBY), Biogen Inc. (NASDAQ: BIIB) and…

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of antiviral drugs, announced that its phase II clinical trial evaluating NV-387 Oral Gummies as a treatment for Bundibugyo ebolavirus and other Ebola viruses in the Democratic Republic of Congo (“DRC”) has been registered in the Pan African Clinical Trials Registry under identification number PACTR202608748555077. The company previously received local regulatory approval from ACOREP to begin the trial and said NV-387 has been delivered to the clinical trial site in Ituri province, with first patient dosing anticipated within one to two weeks, barring outbreak-related impediments. The adaptive trial will begin with a single-arm safety and dose run-in before progressing to a randomized, controlled, open-label efficacy evaluation. NanoViricides said NV-387 is an orally administered broad-spectrum antiviral designed to mimic host-side features required by viruses for infection and is also being evaluated in a phase II clinical trial for Mpox in the DRC.

Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company, announced that its Information Data Exchange(R) (“IDE(R)”), NIL Vault (“NILv(TM)”) and American Political Exchange (“APEX(TM)”) are scheduled to launch Sept. 15, marking the company transition from infrastructure development toward commercial deployment. IDE(R), the company flagship exchange platform, is designed to enable data and other real-world assets to be authenticated, valued, tokenized and monetized while allowing owners to retain control of their underlying data. NILv(TM) applies Datavault AI technology to name, image and likeness rights, while APEX(TM) is designed for political data and related information assets. The platforms will also incorporate capabilities from NYIAX, which Datavault AI acquired Aug. 19, including exchange technology, blockchain settlement infrastructure and four issued U.S. patents. CEO Nathaniel Bradley said the company focus following the launch will be driving adoption, scaling the platforms and converting commercial opportunities into revenue.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced that it received a Sept. 2 Notice of Publication from the U.S. Patent and Trademark Office (“USPTO”) for commercial brand name trademarks associated with its lead abuse-deterrent fentanyl transdermal system. The trademarks will be published in the USPTO Trademark Official Gazette and, if no objections are filed during the 30-day opposition period, the USPTO is expected to issue a Notice of Allowance. The fentanyl system incorporates Nutriband AVERSA(TM) abuse-deterrent transdermal technology and is being developed as a patch designed to deter abuse and misuse and reduce the risk of accidental exposure to transdermal fentanyl. Nutriband said the product has potential peak annual U.S. sales of $80 million to $200 million, while its AVERSA(TM) technology is protected by patents issued in 46 countries.

Greenland Mines (NASDAQ: GRML) announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. Nasdaq has formally approved the company application relating to its March 2026 transaction, resolving prior deficiencies and bringing Greenland Mines into full compliance with listing requirements. The company also completed its acquisition of the Sarfartoq project on Sept. 1 following approval by the Government of Greenland. An independent S-K 1300 Initial Assessment for the ST1 deposit estimated a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%. Greenland Mines said planned annual neodymium-praseodymium oxide production from ST1 would equal approximately 34% of current NdPr oxide refining outside China based on 2025 consumption levels during each of the project nine scheduled operating years. The company is also reshaping its board, with Riad El-Dada and Dr. Shalom Hirschman stepping down and capital markets veteran Jason Hawkins joining as Greenland Mines advances Sarfartoq and its Skaergaard palladium-gold-platinum project.